Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives
19/09/2024 21:10
Sept 19 (Reuters) - Notable Labs Ltd NTBL.O :
* NOTABLE LABS LTD - APPROVED A STREAMLINED OPERATING PLAN
WHICH
INCLUDES EXPLORING STRATEGIC ALTERNATIVES
* NOTABLE LABS LTD - APPROVED IMMEDIATELY PAUSING
IMPLEMENTATION
OF PLANNED PHASE 2 STUDY OF VOLASERTIB IN RELAPSED/REFRACTORY
AML (R/R AML)
* NOTABLE LABS LTD - APPROVED REDUCTION IN CO'S EMPLOYEE
WORKFORCE
AND OUTSIDE CONSULTANTS BY ABOUT 65%
* NOTABLE LABS LTD - ANTICIPATES RECOGNIZING APPROXIMATELY
$0.1
MILLION IN TOTAL CHARGES IN CONNECTION WITH REDUCTION IN FORCE
Source text for Eikon: ID:n0001493152-24-037122
Further company coverage: NTBL.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives